Profile of Childhood Cancers From Hospital-Based Cancer Registries in India, 2012-19

Gauri Kapoor1, Ramandeep Singh Arora2, Venkatraman Radhakrishnan3

  • 1Department of Pediatric Hematology Oncology, Rajiv Gandhi Cancer Institute and Research Centre, Delhi.

Indian Pediatrics
|January 6, 2024
PubMed

Insights

Childhood cancers represent a significant portion of all cancer cases in India, with leukemia being the most common. These pediatric and adolescent cancers show a notable male predominance, guiding future research and health strategies.

Area of Science:

  • Oncology
  • Pediatric Oncology
  • Epidemiology

Background:

  • Childhood and adolescent cancers are a significant global health concern.
  • Understanding the epidemiological patterns of these cancers is crucial for effective public health strategies.
  • Hospital-based cancer registries provide valuable data for analyzing cancer trends.

Purpose of the Study:

  • To delineate the clinical and epidemiological patterns of childhood and adolescent cancers in India.
  • To utilize data from the National Cancer Registry Program for comprehensive analysis.
  • To inform research and planning strategies for pediatric cancers in India.

Main Methods:

  • A retrospective review of 60,720 cancer cases aged 0-19 years from 2012-2019.
  • Data sourced from 96 hospital-based cancer registries across India.
  • Classification of cancers based on the International Classification of Childhood Cancer (ICCC) and descriptive statistical analysis.

Main Results:

  • Pediatric cancers (0-19 years) constituted 4.6% of all cancer cases in India.
  • Leukemia was the most prevalent cancer, followed by lymphoma, central nervous system tumors, and bone cancers.
  • A male-to-female ratio of approximately 1.7:1 was observed for childhood and adolescent cancers.

Conclusions:

  • Childhood and adolescent cancers form a substantial part of the overall cancer burden in India.
  • The observed male preponderance in these age groups requires further investigation.
  • This epidemiological data is vital for refining national cancer control and research initiatives.
Abstract

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.2K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
195
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K